Earlier this month Oracle closed its $28.3B acquisition of Cerner and shortly after Oracle founder and CTO, Larry Ellison, outlined Oracle’s vision for Healthcare IT post-acquisition. The key elements of this vision included: - Developing a solution for a national EHR database. - Leveraging this solution, and similar smaller-scale connected EHR initiatives, to provide life science, pharma and other users with a rich environment for research, clinical trials and drug
Read More
Wavemaker Three-Sixty Health Closes $64M Fund to Invest in Early-Stage Startups
What You Should Know: - Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, recently announced its Fund II news, closing at $64M, surpassing its first fund nearly four times over. - The goal for Fund II is to invest into 40-50 early-stage companies, with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health,
Read More
H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data
What You Should Know: - H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M. - The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More
Insilico Medicine Raises $60M, Launches AI-powered Drug Discovery Robotics Laboratory
What You Should Know: - Insilico Medicine, an NYC-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company raises $60 million in Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors. - Insilico is also launching a new state-of-the-art robotics lab and fully robotic biological data factory. They have seen a string of successes thus far in 2022, including the
Read More
PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth
What You Should Know: - A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns. - Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year
Read More
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis. As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
C2i Genomics Brings Distributed Cancer Monitoring to Cancer Centers Across Europe
What You Should Know: - C2i Genomics, a cancer intelligence company launches its C2inform minimal residual disease (MRD) test across Europe, after obtaining CE-IVD marking in the EU, UK and Switzerland. The company also announced the completion of several clinical trials across the globe, including leading cancer centers in Europe, U.S. and Singapore. - The new clinical data will be presented at the 2022 American Association for Cancer Research (AACR) annual meeting in New Orleans,
Read More
Doceree Lands $11M for Physician-Only Platform for Precision Marketing
What You Should Know: - Doceree, a global network of HCP-only platforms for programmatic messaging raises $11M in a Series A funding round led by Eight Roads Ventures to enrich programmatic messaging offerings for health information technology (HIT) platforms to improve the distribution of hyper-relevant messages to prescribers. The round also included participation from F-Prime Capital and Alkemi Growth Capital. -
Read More
Nurse-1-1 Raises $2.3M to Expand Conversational Marketing for Healthcare
What You Should Know: - Nurse-1-1, the first conversational marketing company for healthcare raises $2.3M in seed funding round led by Argon Ventures with participation from York IE and Hyperplane. - The company will use the financing to expand its team, accelerate its go-to-market efforts, and scale its current partnerships with publicly traded and nationwide digital health, at-home testing, and pharma companies. Nationwide Nurse Work Through a
Read More
VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials
What You Should Know: - VivoSense, an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data raises $25 Million in Series A funding. - The financing will accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital
Read More